In addition, silencing of EGFR significantly rescued FBXL2 knockdown-induced tumor growth in H292 xenograft mouse model (Fig. 4e, f), indicating that silencing of FBXL2 promotes NSCLC cell proliferation and tumor growth via up-regulation of EGFR expression. The gene discussed is FBXL2; the disease is neoplasm.